Andrew E. Sloan, MD, FACS Neurosurgeon
Get to know Neurosurgeon Dr. Andrew E. Sloan, who serves patients throughout the states of Georgia, Ohio, California, Florida, and Michigan.
Dr. Sloan is a nationally and internationally renowned neurosurgeon, physician-scientist, & noted as one of the pioneers in the immunotherapy of brain tumors. He has had an interest in neuroscience, cancer biology, and the desire to make a difference for over three decades.
Despite his busy surgical schedule of more than 300 brain surgeries a year, he continues to be on the forefront of surgical and non-surgical treatments in neurosurgery, his expertise is in benign brain tumors, gliomas, immunotherapy, laser interstitial thermotherapy, malignant brain tumors, meningioma, minimally invasive brain surgery, spinal oncology, and tumor vaccines.
Dr. Sloan currently serves as the Chief of Neurosciences at Piedmont Healthcare in Atlanta, Georgia, where he practices as a Neurosurgical Oncologist. He also serves as Adjunct Professor of Neurological Surgery and Pathology at the Case Comprehensive Cancer Center and the Case Western Reserve University School of Medicine. From 2007-2022, Dr. Sloan served as the Peter D. Cristal Chair in Neurosurgery at University Hospitals & Vice Chairman of the Department of Neurosurgery at Case Western Reserve University School of Medicine; Director of the Brain Tumor and Neuro-Oncology Center at the Center of Excellence for Translational Neuro-Oncology, Case Comprehensive Cancer Center; Distinguished Surgeon & Senior Staff Neurosurgeon at University Hospitals Cleveland Medical Center, as well as Staff Neurosurgeon at UH Rainbow Babies & Children’s Hospital.
Dr. Sloan has also served administratively on many local and national committees including the Chair of the Neuroscience Clinical Guidance Council at Piedmont Health, as well as the Neuroscience Chair of the Piedmont Research Institute.
Nationally, he has led educational and training courses on advanced neurosurgical techniques for practicing neurosurgeons and advanced trainees at both the American Association of Neurological Surgery (AANS) and the Congress of Neurosurgery (CNS). He has also served on many national committees including the Neurosurgery Committee of the NCI-funded NRG consortium; the Panel on Musculoskeletal Imaging of the American College of Radiology; and on serves on the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) at the Center for Medicare/Medicaid Services (CMS). At University Hospitals of Cleveland, he served as the Director of the Cord Compression Steering Committee, the Budget & Finance Committee, the Quality Committee, and on the Physician Advisory Board.
Driven by a lifelong desire to become a physician, Dr. Sloan graduated from Yale University, with a Bachelor of Science degree in Biology, magna cum laude, and earned his MD from Harvard Medical School. He served his internship in general surgery, and residency in neurosurgery, as well as a research fellowship at the UCLA School of Medicine. He subsequently completed a fellowship in neurosurgical oncology & skull-base neurosurgery at the MD Anderson Cancer Center in Houston, Texas. In 2020, Dr. Sloan earned his Master of Business Administration (with healthcare specialization) from Baldwin Wallace University. He is board-certified in neurosurgery by the American Board of Neurological Surgery (ABNS).
Active in local and national organizations, Dr. Sloan is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, A fellow of the American College of Surgeons (FACS), the American College of Surgeons Oncology Group, the American Academy of Neurosurgery, the AANS/CNS Spine Section, the American Society of Clinical Oncology, the Society of Neuro-Oncology, the American Society for Therapeutic Radiation Oncology, the American Association for Cancer Research, the Georgia Neurosurgical Society, the American Association for the Advancement of Science, the International Society for Biological Therapy of Cancer, the National Association for the Advancement of Colored People, the Ohio State Medical Association, and the Ohio State Neurosurgical Society (of which he is Chair Emeritus).
As a recognized leader in neurosurgery, he has served on the FDA Committee for Drugs and Devices, as well as numerous committees of the American Association of Neurosurgery including the AANS Founder’s Club, the Scientific Program Committee, the Coding & Reimbursement Committee, the Executive Council for Drugs and Devices Committee, as well as a mentor of the Resident Mentoring Program.
Among his other activities, Dr. Sloan has served as a member or moderator of the Annual Scientific Meeting at AANS/CNS Joint Sections on Tumors; the Appropriateness Criteria Committee of the American College of Radiology; the Skeletal Metastasis Guidelines at the American College of Radiology; the Atlanta Chapter of the American College of Surgeons; the Bone Metastasis Panel of the American Radium Society; the Editorial Board of Operative Neurosurgery; a Founding member of the Glioma Longitudinal Analysis (GLASS) Consortium; the Ezekiel Hershey Council at Harvard Medical School; the Catalyst Council of the New England Journal of Medicine; the Neurosurgical and Brain Tumor Committees of the Radiation Therapy Oncology Group (RTOG); a Founding member of the Society for Melanoma Research; and a mentor of the Young Investigator Committee of the Society for Neuro-Oncology.
The Associate Editor of Operative Neurosurgery, Dr. Sloan also serves on the following editorial board of several neurosurgical and scientific journals, including: Acta Neuropathologica (Ad Hoc), AANS Neurosurgery Newsletter, Annals of Surgical Oncology (Ad Hoc), BMC Neurology (Ad Hoc), Brain (Ad Hoc), Cancer (Ad Hoc), Clinical Cancer Research (Ad Hoc), Cancer Immunology and Immunotherapy (Ad Hoc), Cancer Management and Research (Ad Hoc), Cancer Research (Ad Hoc), Case Reports in Medicine (Ad Hoc), Clinical Cancer Research (Ad Hoc), Frontiers in Immunology (Ad Hoc), Human Immunology (Ad Hoc), Journal of Clinical Investigation (Ad Hoc), Journal of Clinical Oncology (Ad Hoc), Journal of Immunotherapy (Ad Hoc), Journal for Immunotherapy of Cancer (Ad Hoc), Journal of Neurology, Psychiatry and Neurosurgery (Ad Hoc), Journal of the Neurological Sciences (Ad Hoc), Journal of Neuroscience (Ad Hoc), Journal of Neurosurgery (Ad Hoc), Melanoma Research (Ad Hoc), Nature: Scientific Reports (Ad Hoc), Neurological Research, (Ad Hoc), Neurosurgery (Ad Hoc), Neuro-Oncology (Ad Hoc), New England Journal of Medicine, Oncotarget (Ad Hoc), Plos One (Ad Hoc), Select Review in Neuro-Oncology (Ad Hoc), Neuro-Oncology (Ad Hoc), and World Neurosurgery (Ad Hoc).
Throughout his extensive career, Dr. Sloan has authored more than 240 peer-reviewed publications, holds 6 US patents and INDs, and more than 650 invited presentations. He also appears regularly on local, regional and national news broadcasts as a brain cancer expert.
In recognition of his commitment to medicine, Dr. Sloan has been recognized as one of the “Best Doctors in America” since 2003, a Castle-Connolly Top Doctor since 2004, and sited as one of the “Top Surgeons in America” since 2007.
By advancing brain cancer research and surgical techniques, he hopes to help people suffering from these conditions live as many good years as possible.
Learn More about Dr. Andrew E. Sloan Through his findatopdoc profile, https://www.findatopdoc.com/doctor/1639429-Andrew-Sloan-Neurosurgeon, through his website, https://www.andrewesloanlab.com/ or through Case Western Reserve University School of Medicine, https://case.edu/medicine/neurosurgery/meet-our-team/faculty/andrew-e-sloan
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know-how to make informed decisions for you and your family.
